Table 5 Odds ratios for breast cancer according to duration for 'exclusive use' of individual SSRIs

No use ^d (reference)

1,442

(84.8)

14,415

(84.7)

1.00

1.00

Paroxetine

1 to 23

57

(3.8)

482

(3.2)

1.18 (0.89, 1.56)

1.17 (0.88, 1.55)

≥24

11

(0.73)

89

(0.6)

1.24 (0.66, 2.32)

1.20 (0.64, 2.25)

Sertraline

1 to 23

22

(1.5)

240

(1.6)

0.92 (0.59, 1.42)

0.92 (0.59, 1.42)

≥24

8

(0.5)

44

(0.3)

1.82 (0.85, 3.87)

1.84 (0.86, 3.93)

Fluoxetine

1 to 23

38

(2.6)

483

(3.2)

0.79 (0.56, 1.10)

0.79 (0.56, 1.10)

≥24

1

(0.7)

134

(0.9)

0.82 (0.44, 1.52)

0.81 (0.44, 1.51)

Fluvoxamine

1 to 23

18

(1.2)

174

(1.2)

1.03 (0.64, 1.69)

1.02 (0.63, 1.67)

≥24

4

(0.3)

30

(0.2)

1.33 (0.47, 3.79)

1.33 (0.47, 3.77)

Citalopram ^e

1 to 23

9

(0.6)

133

(0.9)

Not estimatable

Not estimatable

≥24

0

(0.0)

9

(0.1)